TY - JOUR
T1 - Structure function relationships in the lymphatic system and implications for cancer biology
AU - Witte, Marlys H
AU - Jones, Kimberly
AU - Wilting, Jörg
AU - Dictor, Michael
AU - Selg, Manuel
AU - McHale, Noel
AU - Gershenwald, Jeffrey E
AU - Jackson, David G
N1 - Funding Information:
“...for even if one were to accept without reservation the view that the lymph nodes help to prevent the spread of infection or of malignant growths, it is obvious that the lymphatic vessels facilitate this spread. Any barrier action of the lymph nodes is more than offset by the dangerously rapid extension of disease that lymphatic vessels render possible. One has only to contemplate, for example, the case of a small epithelioma on the back of the hand with axillary metastases, a small septic wound with angry red lines running up to the axilla, or a carcinoma of the breast which has spread to the liver via the internal mammary lymph pathway or the lymphatics of the rectus sheath, to [ask the question], as far as barrier action is concerned, [would] the patient perhaps be better off had he possessed neither lymphatic vessels nor nodes?” (JM Yoffey and FC Courtice, 1970 [4]) Acknowledgments Drs. Witte and Jones acknowledge the collaboration of M. Bernas and the late C. Witte (University of Arizona) and support from grants NIH RO1HL48493, R13HL64615, R21AT00405, Arizona Disease Control Research Commission Contracts 8277-000000-1-1-AT-6625, ZB-7492, I-103 and American Cancer Society, RSGTL-05-090-01-CCE. Dr. Wilting acknowledges support from grant WI 1452/8-1 from the Deutsche Forschungsgemeinschaft. Dr. Dictor acknowledges the technical collaboration of Thomas Samson and Lydia Sorokin, and support from Swedish Cancer Fund grant 482, project 4244-B00-02XBB and from the Lund University Medical Faculty. Dr. Jackson acknowledges the generous support of Cancer Research UK who have funded research project grant C581 and CRUK project grant A5999, and the ongoing support of the UK Medical Research Council.
PY - 2006/6
Y1 - 2006/6
N2 - The lymphatic system, composed of lymphatic vessels, lymph, lymph nodes, and lymphocytes, is a distinctive vasculature (discontinuous basement membrane, open endothelial junctions, anchoring filaments, valves, and intrinsic contractility), different yet similar to the blood vasculature; an integral component of the plasma-tissue fluid-lymph circulation (the "blood-lymph loop"); and the center of the immunoregulatory network. Lymphatics are involved in diverse developmental, growth, repair, and pathologic processes both analogous to and distinct from those affecting the blood vasculature. Interference with the blood-lymph loop produces swelling [an imbalance between lymph formation (regulated by Starling's law of transcapillary fluid exchange) and lymph absorption], scarring, nutritional and immunodysregulatory disorders, as well as disturbances in lymph(hem)angiogenesis (lymphedema-angiodysplasia syndromes). The lymphatic system is also the stage on which key events during cancer development and progression are played out, and historically, also forms the basis for current evaluation, prognostication, and/or both operative and non-operative treatment of most cancers. Recent advances in molecular lymphology (e.g., discovery of lymphatic growth factors, endothelial receptors, transcription factors, genes, and highly specific immunohistochemical markers) and growing interest in lymphangiogenesis, combined with fresh insights and refined tools in clinical lymphology, including non-invasive lymphatic imaging, are opening up a window for translation to the clinical arena. Therefore, in cancer biology, attention to the multifaceted structure-function relationships within this vast, relatively unexplored system is long overdue.
AB - The lymphatic system, composed of lymphatic vessels, lymph, lymph nodes, and lymphocytes, is a distinctive vasculature (discontinuous basement membrane, open endothelial junctions, anchoring filaments, valves, and intrinsic contractility), different yet similar to the blood vasculature; an integral component of the plasma-tissue fluid-lymph circulation (the "blood-lymph loop"); and the center of the immunoregulatory network. Lymphatics are involved in diverse developmental, growth, repair, and pathologic processes both analogous to and distinct from those affecting the blood vasculature. Interference with the blood-lymph loop produces swelling [an imbalance between lymph formation (regulated by Starling's law of transcapillary fluid exchange) and lymph absorption], scarring, nutritional and immunodysregulatory disorders, as well as disturbances in lymph(hem)angiogenesis (lymphedema-angiodysplasia syndromes). The lymphatic system is also the stage on which key events during cancer development and progression are played out, and historically, also forms the basis for current evaluation, prognostication, and/or both operative and non-operative treatment of most cancers. Recent advances in molecular lymphology (e.g., discovery of lymphatic growth factors, endothelial receptors, transcription factors, genes, and highly specific immunohistochemical markers) and growing interest in lymphangiogenesis, combined with fresh insights and refined tools in clinical lymphology, including non-invasive lymphatic imaging, are opening up a window for translation to the clinical arena. Therefore, in cancer biology, attention to the multifaceted structure-function relationships within this vast, relatively unexplored system is long overdue.
KW - Animals
KW - Endothelial Cells/physiology
KW - Humans
KW - Lymph Nodes/physiology
KW - Lymphangiogenesis/genetics
KW - Lymphatic Metastasis
KW - Lymphatic System/anatomy & histology
KW - Lymphatic Vessels/pathology
KW - Lymphedema/genetics
KW - Neoplasms/pathology
KW - Neovascularization, Pathologic
KW - Vascular Endothelial Growth Factor Receptor-3/physiology
KW - Lymphatic system
KW - Lymphatic contractility
KW - Tumor lymphangiogenesis
KW - Metastasis
KW - Structure-function
KW - Cancer biology
KW - Lymphatic embryology
KW - Lymphatic endothelium
KW - Stem cells
KW - Sentinel nodes
KW - Lymphatic markers
UR - http://www.scopus.com/inward/record.url?scp=33745070553&partnerID=8YFLogxK
U2 - 10.1007/s10555-006-8496-2
DO - 10.1007/s10555-006-8496-2
M3 - Article
C2 - 16770531
SN - 0167-7659
VL - 25
SP - 159
EP - 184
JO - Cancer and Metastasis Reviews
JF - Cancer and Metastasis Reviews
IS - 2
ER -